Literature DB >> 29064946

Synthetic cannabinoids: A review of the clinical implications of a new drug of choice.

Shaina A Freund1, Adrian S Banning.   

Abstract

Synthetic marijuana use is an emerging public health problem in the United States, and can cause agitation, severe psychosis, bizarre hallucinations, and possibly death. This article describes these products, which are unregulated and can vary widely in composition, and how clinicians can recognize patients with synthetic cannabinoid toxicity and treat them appropriately to minimize morbidity and mortality.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29064946     DOI: 10.1097/01.JAA.0000525914.28344.e2

Source DB:  PubMed          Journal:  JAAPA        ISSN: 0893-7400


  3 in total

1.  Brodifacoum-contaminated synthetic marijuana: clinical and radiologic manifestations of a public health outbreak causing life-threatening coagulopathy.

Authors:  Babita Panigrahi; Blake C Jones; Steven P Rowe
Journal:  Emerg Radiol       Date:  2018-07-18

Review 2.  Cannabinoid exposure during pregnancy and its impact on immune function.

Authors:  Catherine Dong; Jingwen Chen; Amy Harrington; K Yaragudri Vinod; Muralidhar L Hegde; Venkatesh L Hegde
Journal:  Cell Mol Life Sci       Date:  2018-10-29       Impact factor: 9.261

Review 3.  Overview of Synthetic Cannabinoids ADB-FUBINACA and AMB-FUBINACA: Clinical, Analytical, and Forensic Implications.

Authors:  Carolina Lobato-Freitas; Andreia Machado Brito-da-Costa; Ricardo Jorge Dinis-Oliveira; Helena Carmo; Félix Carvalho; João Pedro Silva; Diana Dias-da-Silva
Journal:  Pharmaceuticals (Basel)       Date:  2021-02-25
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.